Reports Q4 revenue $858.5M, consensus $834.9M. Commenting on the results, Al White, Cooper’s president and CEO said, "We started the year on a positive note with double-digit organic revenue growth and strong operational performances at both CooperVision and CooperSurgical. We’re continuing to focus on operational execution combined with prudent investment activity to drive long-term sustainable growth."
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on COO:
- CooperCompanies Announces First Quarter 2023 Results
- CooperCompanies to Present at KeyBanc Life Sciences & MedTech Investor Forum
- CooperCompanies to Present at Oppenheimer’s 33rd Annual Healthcare Conference
- CooperCompanies Announces Release Date for First Quarter 2023
- Cooper Companies price target raised to $385 from $375 at Mizuho